Please assess the completion status of the following clinical trial:

Trial Title: Assessment of Radial Artery Complications Whilst Achieving Rapid Haemostasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Pre-Cath Lab Inclusion Criterion:~Patients scheduled for angiographic procedure with proposed radial access, regardless of their gender identity, ethnicity and religious belief~Pre-Cath Lab Exclusion Criteria:~* \< 18 years of age~* Planned bilateral radial access~* Any haematoma (\> 5 cm in its longest dimension) at planned puncture site prior to radial sheath insertion~* Established diagnosis of any haematologic disorder or genetic defect predisposing to bleeding~* Patients with International Normalised Ratio (INR) \> 2.5 prior to the scheduled angiographic procedure~* Inability to perform adequate consent: communication issues (e.g. mental capacity); inadequate time for the participant to read and consider trial; unscheduled Urgent or Emergency procedures i.e. PPCI~* Patients who are scheduled to be transferred to other hospitals (treat and return) before haemostasis is achieved.~* Electronic Patient Record technical failure leading to an inability to record participants' care~In-Cath Lab Inclusion Criterion:~Single radial sheath in situ with planned removal in lab~In-Cath Lab Exclusion Criteria:~* Sheath removal after 17:00 hrs~* Patient leaving lab with radial sheath in situ~* Trans-ulnar procedure~* Distal (snuffbox) trans-radial procedure~* Any puncture-related haematoma (\> 5cm in its longest dimension) prior to radial sheath removal~* Randomisation system not available~* Dressings of both types not available~* A change in patient's clinical condition during procedure deemed by the operator sufficient to exclude from the trial~* Procedural complication requiring procedure termination

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Conventional dressing with 120 minutes external compression (Type: ACTIVE_COMPARATOR): A standard absorbent dressing is placed on the radial access site, following the transradial angiographic procedure. A radial compression device is then applied to secure patent haemostasis, once the radial sheath is removed. The compression device remains in place for a minimum of 2 hours, as per protocol. This is the standard radial care currently in use at Liverpool Heart and Chest Hospital.
- Conventional dressing with 60 minutes external compression (Type: EXPERIMENTAL): A standard absorbent dressing is placed on the radial access site, following the transradial angiographic procedure. A radial compression device is then applied to secure patent haemostasis, once the radial sheath is removed. The compression device remains in place for a minimum of 1 hour, as per protocol.
- Haemostatic dressing with 60 minutes external compression (Type: EXPERIMENTAL): A haemostatic absorbent dressing is placed on the radial access site, following the transradial angiographic procedure. This consists of a mineral-based dressing that accelerates local haemostasis. A radial compression device is then applied to secure patent haemostasis, once the radial sheath is removed. The compression device remains in place for a minimum of 1 hour, as per protocol.

Based on this trial design, predict the completion outcome and termination type (if applicable).